Strome; Scott E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Strome; Scott E..The latest application filed is for "t-cell receptor for treating fibrolamellar hepatocellular carcinoma".

Company Profile

6.23.40

Strome; Scott E. - Reisterstown MD
STROME; Scott E. - Memphis TN
Strome; Scott E. - Rochester MN
STROME; Scott E. - Baltimore MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Universal antibody-mediated biosensor Grant 11,440,946 - Schulze , et al. September 13, 2	2022-09-13
T-Cell Receptor for Treating Fibrolamellar Hepatocellular Carcinoma App 20220251167 - THOMAS; Paul ; et al.	2022-08-11
Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target Grant 11,242,387 - Chen , et al. February 8, 2	2022-02-08
Costimulatory B7-h1 In Renal Cell Carcinoma Patients: Indicator Of Tumor Aggressiveness And Potential Therapeutic Target App 20210380690 - Chen; Lieping ; et al.	2021-12-09
Immunoglobulin Constant Region Fc Receptor Binding Agents App 20210277091 - STROME; Scott E. ; et al.	2021-09-09
Inhibition Of Zscan4 For Inhibition Of Tumor Growth App 20210079402 - Zalzman; Michal ; et al.	2021-03-18
Immunoglobulin constant region Fc receptor binding agents Grant 10,941,191 - Strome , et al. March 9, 2	2021-03-09
Immunoglobulin constant region Fc receptor binding agents Grant 10,851,154 - Strome , et al. December 1, 2	2020-12-01
Costimulatory B7-h1 In Renal Cell Carcinoma Patients: Indicator Of Tumor Aggressiveness And Potential Therapeutic Target App 20200002419 - Chen; Lieping ; et al.	2020-01-02
Immunoglobulin Constant Region Fc Receptor Binding Agents App 20190218275 - STROME; Scott E. ; et al.	2019-07-18
Immunoglobulin constant region Fc receptor binding agents Grant 10,208,105 - Strome , et al. Feb	2019-02-19
Immunoglobulin Constant Region Fc Receptor Binding Agents App 20180186862 - STROME; Scott E. ; et al.	2018-07-05
Costimulatory B7-h1 In Renal Cell Carcinoma Patients: Indicator Of Tumor Aggressiveness And Potential Therapeutic Target App 20180179281 - Chen; Lieping ; et al.	2018-06-28
Costimulatory B7-h1 In Renal Cell Carcinoma Patients: Indicator Of Tumor Aggressiveness And Potential Therapeutic Target App 20180100015 - Chen; Lieping ; et al.	2018-04-12
Immunoglobulin constant region Fc receptor binding agents Grant 9,926,362 - Strome , et al. March 27, 2	2018-03-27
Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target Grant 9,803,015 - Chen , et al. October 31, 2	2017-10-31
Immunoglobulin Constant Region Fc Receptor Binding Agents App 20170218049 - STROME; Scott E. ; et al.	2017-08-03
Immunoglobulin Constant Region Fc Receptor Binding Agents App 20160355570 - Strome; Scott E. ; et al.	2016-12-08
Immunoglobulin constant region FC receptor binding agents Grant 9,512,208 - Strome , et al. December 6, 2	2016-12-06
Immunoglobulin constant region Fc receptor binding agents Grant 9,512,210 - Strome , et al. December 6, 2	2016-12-06
Immunoglobulin Constant Region Fc Receptor Binding Agents App 20160280768 - Strome; Scott E. ; et al.	2016-09-29
Costimulatory B7-h1 In Renal Cell Carcinoma Patients: Indicator Of Tumor Aggressiveness And Potential Therapeutic Target App 20160264667 - Chen; Lieping ; et al.	2016-09-15
Costimulatory B7-h1 In Renal Cell Carcinoma Patients: Indicator Of Tumor Aggressiveness And Potential Therapeutic Target App 20160257953 - Chen; Lieping ; et al.	2016-09-08
Costimulatory B7-h1 In Renal Cell Carcinoma Patients: Indicator Of Tumor Aggressiveness And Potential Therapeutic Target App 20160245816 - Chen; Lieping ; et al.	2016-08-25
Immunoglobulin Constant Region Fc Receptor Binding Agents App 20150056185 - STROME; SCOTT E. ; et al.	2015-02-26
Costimulatory B7-h1 In Renal Cell Carcinoma Patients: Indicator Of Tumor Aggressiveness And Potential Therapeutic Target App 20150044165 - CHEN; Lieping ; et al.	2015-02-12
Immunoglobulin Constant Region Fc Receptor Binding Agents App 20140335075 - Strome; Scott E. ; et al.	2014-11-13
Enhancement of immune responses by 4-1 BB-binding agents Grant 8,772,026 - Chen , et al. July 8, 2	2014-07-08
B7-H1 and methods of diagnosis, prognosis, and treatment of cancer Grant 8,747,833 - Chen , et al. June 10, 2	2014-06-10
Immunoglobulin Constant Region Fc Receptor Binding Agents App 20140105913 - STROME; Scott E. ; et al.	2014-04-17
Immunoglobulin constant region FC receptor binding agents Grant 8,680,237 - Strome , et al. March 25, 2	2014-03-25
Immunoglobulin Constant Region Fc Receptor Binding Agents App 20120309941 - STROME; SCOTT E. ; et al.	2012-12-06
HPV 16 peptide vaccine for head and neck cancer Grant 8,263,560 - Strome , et al. September 11, 2	2012-09-11
Enhancement of Immune Responses By 4-1BB-Binding Agents App 20120225043 - Chen; Lieping ; et al.	2012-09-06
Enhancement of immune responses by 4-1BB-binding agents Grant 8,163,550 - Chen , et al. April 24, 2	2012-04-24
Method Of Using An Anti-cd137 Antibody As An Agent For Radioimmunotherapy Or Radioimmunodetection App 20120058047 - Strome; Scott E. ; et al.	2012-03-08
Methods Of Enhancing T Cell Responsiveness App 20120027759 - Chen; Lieping ; et al.	2012-02-02
B7-h1 And Methods Of Diagnosis, Prognosis, And Treatment Of Cancer App 20110200620 - CHEN; Lieping ; et al.	2011-08-18
Method Of Using An Anti-cd137 Antibody As An Agent For Radioimmunotherapy Or Radioimmunodetection App 20110104049 - Strome; Scott E. ; et al.	2011-05-05
Mage-a3/hpv 16 Peptide Vaccines For Head And Neck Cancer App 20110070252 - Strome; Scott E. ; et al.	2011-03-24
B7-H1 and methods of diagnosis, prognosis, and treatment of cancer Grant 7,892,540 - Chen , et al. February 22, 2	2011-02-22
Enhancement of Immune Responses By 4-1BB-Binding Agents App 20100266611 - Chen; Lieping ; et al.	2010-10-21
Immunoglobulin Constant Region Fc Receptor Binding Agents App 20100239633 - Strome; Scott E. ; et al.	2010-09-23
Methods of enhancing T cell responsiveness Grant 7,794,710 - Chen , et al. September 14, 2	2010-09-14
Mage-a3/hpv 16 Peptide Vaccines For Head And Neck Cancer App 20100183646 - STROME; Scott E. ; et al.	2010-07-22
Enhancement of immune responses by 4-1bb-binding agents Grant 7,651,686 - Chen , et al. January 26, 2	2010-01-26
Direct vaccination of the bone marrow App 20090130144 - Strome; Scott E. ; et al.	2009-05-21
Detection of antibodies specific for B7-H1 in subjects with diseases or pathological conditions mediated by activated T cells Grant 7,449,300 - Chen , et al. November 11, 2	2008-11-11
Mage-a3/hpv 16 Peptide Vaccines For Head And Neck Cancer App 20080044407 - Strome; Scott E. ; et al.	2008-02-21
Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection App 20080019905 - Strome; Scott E. ; et al.	2008-01-24
MAGE-A3/HPV 16 peptide vaccines for head and neck cancer App 20060222656 - Strome; Scott E. ; et al.	2006-10-05
Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection App 20060188439 - Strome; Scott E. ; et al.	2006-08-24
Anti-CD137 antibody as an agent in the treatment of cancer and glycosylation variants thereof App 20060182744 - Strome; Scott E. ; et al.	2006-08-17
B7-H1 and methods of diagnosis, prognosis, and treatment of cancer App 20060083744 - Chen; Lieping ; et al.	2006-04-20
Enhancement of immune responses by 4-1bb-binding agents App 20050013811 - Chen, Lieping ; et al.	2005-01-20
Autoantibodies specific for B7-H1 App 20040180047 - Chen, Lieping ; et al.	2004-09-16
Apparatus and system for stimulating mouth muscles Grant 6,591,140 - Strome , et al. July 8, 2	2003-07-08
Methods of enhancing T cell responsiveness App 20030039653 - Chen, Lieping ; et al.	2003-02-27
Apparatus and system for stimulating mouth muscles App 20020077674 - Strome, Scott E. ; et al.	2002-06-20
Retractable surgical scalpel Grant 6,015,419 - Strome , et al. January 18, 2	2000-01-18

Company Registrations

NCAGE Code	4NYT8	STROME, SCOTT E
CAGE Code	4NYT8	STROME, SCOTT E

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.